Osteoclast Function Biology and Mechanisms

Principles of Bone Biology: Volume 1-2, Third Edition

Volumn , Issue , 2008, Pages 193-209

  Väänänen, H Kalervo ^a   Zhao, Haibo ^b  

^a UNIVERSITY OF TURKU   (Finland)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70349727589     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-373884-4.00030-6     Document Type: Chapter

References (177)

1. E.M. Aarden, E.H. Burger and P.J. Nijweide (1994) Function of osteocytes in bone. J. Cell Biochem. 55 287-299.
2. A.P. Armstrong, M.E. Tometsko, M. Glaccum, C.L. Sutherland, D. Cosman and W.C. Dougall (2002) A RANK/TRAF6-dependent signal transduction pathway is essential for osteoclast cytoskeletal organization and resorptive function. J. Biol. Chem. 277 44347-44356.
3. R. Baron, L. Neff, D. Louvard and P.J. Courtov (1985) Cell-mediated extracellular acidification and bone resorption: Evidence for a low pH in resorbing lacunae and localization of a 100kD lysosomal protein at the osteoclast ruffled border. J. Cell Biol. 101 2210-2222.
4. R. Baron, L. Neff, C. Roy, A. Boisvert and M. Caplan (1986) Evidence for a high and specific concentration of (Na+, K+)ATPase in the plasma membrane of the osteoclast. Cell 46 311-320.
5. R. Baron, L. Neff, W. Brown, P.J. Courtoy, D. Louvard and M.G. Farquhar (1988) Polarized secretion of lysosomal enzymes: Co-distribution of cation-independent mannose-6-phosphate receptors and lysosomal enzymes along the osteoclast exocytic parhway. J. Cell Biol. 106 1863-1872.
6. B.J. Bekker and C.V. Gay (1990) Biochemical characterization of an electrogenic vacuolar proton pump in purified chicken osteoclast plasma membrane vesicles. J. Bone Miner. Res. 5 569-579.
7. B.J. Bekker and C.V. Gay (1990) Characterization of a Ca2+-ATPase in osteoclast plasma membrane. J. Bone Miner. Res. 5 557-567.
8. H.C. Blair and P.H. Schlesinger (1990) Purification of a stilbene sensitive chloride channel and reconstitution of chloride conductivity into phospholipids vesicles. Biochem. Biophys. Res. Commun. 171 920-995.
9. H.C. Blair, S.L. Teitelbaum, R. Ghiselli and S. Gluck (1989) Osteoclastic bone resorption by a polarized vacuolar proton pump. Science 245 855-887.
10. M.J. Bossard, T.A. Tomaszek, S.K. Thompson, B.Y. Amegadzie, C.R. Hanning, C. Jones, J.T. Kurdyla, D.E. McNulty, F.H. Drake, M. Gowen and M.A. Levy (1996) Proteolytic activity of human osteoclast cathepsin K: Expression, purification, activation, and substrate identification. J. Biol. Chem. 271 12517-12524.
11. B.F. Boyce, T. Yoneda, C. Lowe, P. Soriano and G.R. Mundy (1992) Requirement of pp60c-src expressio10r osteoclasts to form ruffled borders and resorb bone in mice. J. Clin. Invest. 90 1622-1627.
12. A. Bruzzaniti, L. Neff, A. Sanjay, W.C. Horne, P. De Camilli and R. Baron (2005) Dynamin forms a Src kinase-sensitive complex with Cbl and regulates podosomes and osteoclast activity. Mol. Biol. Cell. 16 3301-3313.
13. T.L. Burgess, Y. Qian, S. Kaufman, B.D. Ring, G. Van, C. Capparelli, H. Kelley, H. Hsu, W.J. Boyle, C.R. Dunstan, S. Hu and D.L. Lacey (1999) The ligand for osteoprotegerin (OPGL) directly activate mature osteoclasts. J. Cell Biol. 145 527-538.
14. Y. Calle, G.E. Jones, C. Jagger, K. Fuller, M.P. Blundell, J. Chow, T. Chambers and A.J. Thrasher (2004) WASp deficiency in mice results in failure to form osteoclast sealing zones and defects in bone resorption. Blood 103 3552-3561.
15. T.J. Chambers, J.A. Darby and K. Fuller (1985) Mammalian collagenase predisposes bone surfaces to osteoclastic resorption. Cell Tissue Res. 241 671-675.
16. M.A. Chellaiah (2005) Regulation of actin ring formation by rho GTPases in osteoclasts. J. Biol. Chem. 280 32930-32943.
17. M.A. Chellaiah, N. Soga, S. Swanson, S. McAllister, U. Alvarez, D. Wang, S.F. Dowdy and K.A. Hruska (2000) Rho-A is critical for osteoclast podosome organization, motility, and bone resorption. J. Biol. Chem. 275 11993-12002.
18. W. Chen, S. Yang, Y. Abe, M. Li, Y. Wang, J. Shao, E. Li and Y.P. Li (2007) Novel pycnodysostosis mouse model uncovers cathepsin K function as a potential regulator of osteoclast apoptosis and senescence. Hum. Mol. Genet. 16 410-423.
19. O. Destaing, F. Saltel, J.C. Geminard, P. Jurdic and F. Bard (2003) Podosomes display actin turnover and dynamic self-organization in osteoclasts expressing actin-green fluorescent protein. Mol. Biol. Cell. 14 407-416.
20. I. Djaffar, J.P. Caen and J.P. Rosa (1993) A large alteration in the human platelet glycoprotein (integrin beta 3) gene associated with Glanzmann’s thrombastehenia. Hum. Mol. Genet. 2 2183-2185.
21. O. Drory and N. Nelson (2006) The emerging structure of vacuolar ATPases. Physiology 21 317-325.
22. L.T. Duong and G.A. Rodan (1999) The role of integrins in osteoclast function. J. Bone Miner. Metab. 17 1-6.
23. L.T. Duong, P.T. Lakkakorpi, I. Nakamura, M. Machwate, G.A. Nagy and G.A. Rodan (1998) PYK2 in osteoclasts in an adhesion kinase, localized in the sealing zone, activated by ligation of alpha(v)beta3 and phosphorylated by src kinase. J. Clin. Invest. 102 881-892.
24. V.W. Engelman, G.A. Nickols, F.P. Ross, M.A. Horton, D.W. Griggs, S.L. Settle, P.G. Ruminski and S.L. Teitelbaum (1997) A peptidomimetic antagonist of the alpha(v)beta3 integrin inhibits bone resorption in vitro and prevents osteoporosis in vivo. J. Clin. Invest. 99 2284-2292.
25. V. Everts, J.M. Delaisse, W. Korper and W. Beertsen (1998) Cyteine proteinases and matrix metalloproteinases play distinct roles in the subosteoclastic resorption zone. J. Bone Miner. Res. 13 1420-1430.
26. V. Everts, W. Korper, K.A. Hoeben, I.D. Jansen, D. Bromme, K.B. Cleutjens, S. Heeneman, C. Peters, T. Reinheckel, P. Saftig and W. Beertsen (2006) Osteoclastic bone degradation and the role of different cysteine proteinases and matrix metalloproteinases: Differences between calvaria and long bone. J. Bone Miner. Res. 21 1399-1408.
27. R. Faccio, S. Takeshita, A. Zallone, F.P. Ross and S.L. Teitelbaum (2003) c-FMS and the alphavbeta3 integrin collaborate during osteoclast differentiation. J. Clin. Invest. 111 749-758.
28. R. Faccio, S.L. Teitelbaum, K. Fujikawa, J. Chappel, A. Zallone, V.L. Tybulewicz, F.P. Ross and W. Swat (2005) Vav3 regulates osteoclast function and bone mass. Nat. Med. 11 284-290.
29. K.M. Fagerlund, H. Ylipahkala, S.L. Tiitinen, A.J. Janckila, S. Hamilton, O. Maentausta, H.K. Vaananen and J.M. Halleen (2006) Effects of proteolysis and reduction on phosphatase and ROS-generating activity of human tartrate-resistant acid phosphatase. Arch. Biochem. Biophys. 449 1-7.
30. M.D. Fallon (1984) Bone resorbing fluid from osteoclasts is acidic: An in vitro micropuncture study. C.V. Conn, J.R. Fujita, J.R. Potts (Eds) Endocrine Control of Bone and Calcium Metabolism Amsterdam: Elsevier/North Holland 144-146.
31. J.E. Fisher, M.P. Caulfield, M. Sato, H.A. Quartuccio, R.J. Gould, V.M. Garsky, G.A. Rodan and M. Rosenblatt (1993) Inhibition of osteoclastic bone resorption in vivo by echistatin, an “arginyl-glycyl-aspartyl” (RGD)-containing protein. Endocrinology 132 1411-1413.
32. A. Frattini, P.J. Orchard, C. Sobacchi, S. Giliani, M. Abinum, J.P. Mattsson, D.J. Keeling, A.K. Andersson, P. Wallbrandt, L. Zecca, L.D. Notarangelo, P. Vezzoni and A. Villa (2000) Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteoporosis. Nat. Genet. 25 343-346.
33. K. Fuller, C. Murphy, B. Kirstein, S.W. Fox and T.J. Chambers (2002) TNFalpha potently activates osteoclasts, through a direct action independent of and strongly synergistic with RANKL. Endocrinology 143 1108-1118.
34. K. Fuller, B. Kirstein and T.J. Chambers (2007) The regulation and enzymatic basis of bone resorption by human osteoclasts. Clin. Sci. (Lond.) 23 (Epub ahead of print)
35. B.D. Gelb, G.P. Shi, H.A. Chapman and R.J. Desnick (1996) Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency. Science 273 1236-1238.
36. T. Goto, T. Kiyoshima, R. Moroi, T. Tsukuba, Y. Nishimura, M. Himeno, K. Yamamoto and T. Tanaka (1994) Localization of ­cathepsins B, D, and L in the rat osteoclast by immuno-light and -electron microscopy. Histochemistry 101 33-40.
37. M. Gowen, F. Lazner, R. Dodds, R. Kapadia, J. Field, M. Tavaria, I. Bertonelle, F. Drake, S. Zavarselk, I. Tellis, P. Hertzog, C. Debouck and I. Kola (1999) Cathepsin K knockout mice develop osteoporosis due to a deficit in matrix degradation but not demineralization. J. Bone Miner. Res. 14 1654-1663.
38. A. Grey, Y. Chen, I. Paliwal, K. Carlberg and K. Insogna (2000) Evidence for a functional association between phosphatidylinositol 3-kinase and c-src in the spearing response of osteoclasts to colony-stimulating factor-1. Endocrinology 141 2129-2138.
39. G. Gu, T. Hentunen, M. Nars, P.L. Härkönen and H.K. Väänänen (2005) Estrogen protects primary osteocytes against glucocorticoid-induced apoptosis. Apoptosis 10 583-595.
40. G. Gu, M. Mulari, Z. Peng, T. Hentunen and H.K. Väänänen (2005) Apoptosis of osteocytes turns off the inhibition of osteoclasts and triggers local bone resorption. Biochem. Biophys. Res. Commun. 335 1095-1101.
41. J.M. Halleen, S. Raisanen, J.J. Salo, S.V. Reddy, G.D. Roodman, T.A. Hentunen, P.P. Lehenkari, H. Kaija, P. Vihko and H.K. Vaananen (1999) Intracellular fragmentation of bone resorption products by reactive oxygen species generated by osteoclastic tartrate-resistant acid phosphatase. J. Biol. Chem. 274 22907-22910.
42. M. Hayashi, Y. Koshihara, H. Ishibashi, S. Yamamoto, S. Tsubuki, T.C. Saido, S. Kawashima and M. Inomata (2005) Involvement of calpain in osteoclastic bone resorption. J. Biochem. (Tokyo) 137 331-338.
43. A.R. Hayman, S.J. Jones, A. Boyde, D. Foster, W.H. Colledge, M.B. Carlton, M.J. Evans and T.M. Cox (1996) Mice lacking tartrate-resistant acid phosphatase (Acp 5) have disrupted endochondral ossification and mild osteoporosis. Development 122 3151-3162.
44. T.J. Heino, T.A. Hentunen and H.K. Väänänen (2002) Osteocytes inhibit osteoblastic bone resorption through transforming growth factor b: Enhancement by estrogen. J. Cell. Biochem. 85 185-197.
45. M.H. Helfrich, S.A. Nesbitt, P.T. Lakkakorpi, M.J. Barnes, S.C. Bodary, G. Shankar, W.T. Mason, D.L. Mendrick, H.K. Vaananen and M.A. Horton (1996) Beta 1 integrins and osteoclast function: Involvement in collagen recognition and bone resorption. Bone 19 317-328.
46. K. Henriksen, D.J. Leeming, I. Byrjalsen, R.H. Nielsen, M.G. Sorensen, M.H. Dziegiel, T.J. Martin, C. Christiansen, P. Qvist and M.A. Karsdal (2007) Osteoclasts prefer aged bone. Osteoporos. Int. 10 (Epub ahead of print).
47. K.M. Hodivala-Dilke, K.P. McHugh, D.A. Tsakiris, H. Rayburn, D. Crowley, M. Ullman-Cullere, F.P. Ross, B.S. Coller, S. Teitelbaum and R.O. Hynes (1999) Beta3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival. J. Clin. Invest. 103 229-238.
48. K. Holmbeck, P. Bianco, J. Caterina, S. Yamada, M. Kromer, S.A. Kuznetsov, M. Mankani, P.G. Robey, A.R. Poole, I. Pidoux, J.M. Ward and H. Birkedal-Hansen (1999) MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell 99 81-92.
49. M.A. Horton, M.L. Taylor, T.R. Arnett and M.H. Helfrich (1991) Arg-Gly-Asp (RGD) peptides and the anti-vitronectin receptor antibody 23C6 inhibit dentine resorption and cell spreading by osteoclasts. Exp. Cell Res. 195 368-375.
50. Y. Hu, J. Nyman, P. Muhonen, H.K. Vaananen and T. Laitala-Leinonen (2005) Inhibition of the osteoclast V-ATPase by small interfering RNAs. FEBS Lett. 579 4937-4942.
51. D.E. Hugher, K.R. Wright, H.L. Uy, A. Sasaki, T. Yoneda, G.D. Roodman, G.R. Mundy and B.F. Boyce (1995) Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo. J. Bone Miner. Res. 10 1478-1487.
52. D.E. Hughes, A. Dai, J.C. Tiffee, H.H. Li, G.R. Mundy and B.F. Boyce (1996) Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-beta. Nat. Med. 2 1132-1136.
53. I.R. Hurst, J. Zuo, J. Jiang and L.S. Holliday (2004) Actin-related protein 2/3 complex is required for actin ring formation. J. Bone Miner. Res. 19 499-506.
54. J.M. Ilvesaro, P.T. Lakkakorpi and H.K. Vaananen (1998) Inhibition of bone resorption in vitro by a peptide containing the cadherin cell adhesion recognition sequence HAV is due to prevention of sealing zone formation. Exp. Cell Res. 242 75-83.
55. T. Inaoka, G. Bilbe, O. Ishibashi, K. Tezuka, M. Kumegawa and T. Kokubo (1995) Molecular cloning of human cDNA for cathepsin K: Novel cysteine proteinase predominantly expressed in bone. Biochem. Biophys. Res. Commun. 206 89-96.
56. D. Jia, C.A. O’Brien, S.A. Stewart, S.X. Manolagas, S.C. Manolagas and R.S. Weinstein (2006) Glucocorticoids act directly on osteoclasts to increase their life span and reduce bone density. Endocrinology 147 5592-5599.
57. M.R. Johnson, M.H. Polymeropoulos, H.L. Vos, R.I. Ortiz de Luna and C.A. Francomano (1996) A nonsense mutation in the cathepsin K gene observed in a family with pycnodysostosis. Genome Res. 6 1050-1055.
58. S.J. Jones and A. Boyde (1976) Expeirmental study of changes in osteoblastic shape induced by calcitonin and parathyroid extract in an organ culture system. Cell Tissue Res. 169 449-465.
59. H. Kajiya, F. Okamoto, J.P. Li, A. Nakao and K. Okabe (2006) Expression of mouse osteoclast K-CI Co-transporter-1 and its role during bone resorption. J. Bone Miner. Res. 21 984-992.
60. H. Kakegawa, T. Nikawa, K. Tagami, H. Kamioka, K. Sumitani, T. Kawata, M. Drobnic-Kosorok, B. Lenarcic, V. Turk and N. Katunuma (1993) Participation of cathepsin L on bone resorption. FEBS Lett. 321 247-250.
61. J. Kanehisa and J.N. Heersche (1988) Osateoclastic bone resorption: In vitro analysis of the rate of resorption and migration of individual osteoclasts. Bone 9 73-79.
62. J. Kanehisa, T. Yamanaka, S. Doi, K. Turksen, J.N. Heersche, J.E. Aubin and H. Takeuchi (1990) A band of F-actin containing podosomes is involved in bone resorption by osteoclasts. Bone 11 287-293.
63. H.J. Kim, H. Zhao, H. Kitaura, S. Bhattacharyya, J.A. Brewer, L.J. Muglia, F.P. Ross and S.L. Teitelbaum (2006) Glucocorticoids suppress bone formation via the osteoclast. J. Clin. Invest. 116 2152-2160.
64. M.S. Kim, C.J. Day, C.I. Selinger, C.L. Magno, S.R. Stephens and N.A. Morrison (2006) MCP-1-induced human osteoclast-like cells are tartrate-resistant acid phosphatase, NFATc1, and calcitonin receptor-positive but require receptor activator of NFkappaB ligand for bone resorption. J. Biol. Chem. 281 1274-1285.
65. N. Kobayashi, Y. Kadono, A. Naito, K. Matsumoto, T. Yamamoto, S. Tanaka and J. Inoue (2001) Segregation of TRAF6-mediated signaling pathways clarifies its role in osteoclastogenesis. EMBO J. 20 1271-1280.
66. O. Kollet, A. Dar, S. Shivtiel, A. Kalinkovich, K. Lapid, Y. Sztainberg, M. Tesio, R.M. Samstein, P. Goichberg, A. Spiegel, A. Elson and T. Lapidot (2006) Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells. Nat. Med. 12 657-664.
67. U. Kornak, A. Schulz, W. Friedrich, S. Uhlhaas, B. Kremens, T. Voit, C. Hasan, U. Bode, T.J. Jentsch and C. Kubisch (2000) Mutations in the a3 subunit of the vacuolar H(+)ATPase cause infantile malignant osteoporosis. Hum. Mol. Genet. 9 2059-2063.
68. U. Kornak, D. Kasper, M.R. Bosl, E. Kaiser, M. Schweizer, A. Schulz, W. Friedrich, G. Delling and T.J. Jentsch (2001) Loss of the CIC-7 chloride channel leads to osteopetrosis in mice and man. Cell 104 205-215.
69. S. Kumar, L. Dare, J.A. Vasko-Moser, I.E. James, S.M. Blake, D.J. Rickard, S.M. Hwang, T. Tomaszek, D.S. Yamashita, R.W. Marquis, H. Oh, J.U. Jeong, D.F. Veber, M. Gowen, M.W. Lark and G. Stroup (2007) A highly potent inhibitor of cathepsin K (relacatib) reduces biomarkers of bone resorption both in vitro and in an acute model of elevated bone turnover in vivo in monkeys. Bone 40 122-131.
70. K. Kurata, T.J. Heino, H. Higaki and H.K. Väänänen (2006) Bone marrow cell differentiation induced by mechanically damaged ­osteocytes in three-dimensional gel-embedded culture. J. Bone Miner. Res. 21 616-626.
71. T. Laitala and H.K. Väänänen (1994) Inhibition of bone resorption in vitro by antisense RNA and DNA molecules targeted against carbonic anhydrase II of two subunits of vacuolar H+-ATPase. J. Clin. Invest. 93 2311-2380.
72. T. Laitala-Leinonen, R. Rinne, P. Saukko, H.K. Väänänen and A. Rinne (2006) Cystatin B as an intracellular modulator of bone resorption. Matrix Biol. 25 149-157.
73. P. Lakkakorpi and H.K. Väänänen (1990) Calcitonin, PgE2, and cAMP disperse the specific microfilament structure in resorbing osteoclasts. J. Cytochem. Histochem. 38 1487-1493.
74. P.T. Lakkakorpi and H.K. Väänänen (1991) Kinetics of the osteoclast cytoskeleton during the resorption cycle in vitro. J. Bone Miner. Res. 6 817-826.
75. P.T. Lakkakorpi and H.K. Väänänen (1995) Cytoskeletal changes in osteoclasts during the resorption cycle. Microsc. Res. Techn. 32 171-181.
76. P. Lakkakorpi, J. Tuukkanen, T. Hentunen, K. Järvelin and H.K. Väänänen (1989) Organization of osteoclast microfilaments during the attachment to bone surface in vivo. J. Bone Miner. Res. 4 817-825.
77. P.T. Lakkakorpi, M.A. Horton, M.H. Helfrich, E.K. Karhukorpi and H.K. Väänänen (1991) Vitronectin receptor has a role in bone resorption but does not mediate tight sealing zone attachment of osteoclasts to the bone surface. J. Cell Biol. 115 1179-1186.
78. P.T. Lakkakorpi, M.H. Helfrich, M.A. Horotn and H.K. Väänänen (1993) Spatial organization of microfilaments and vitronectin receptor, alpha v beta 3, in osteoclasts: A study using confocal laser scanning microscopy. J. Cell Sci. 104 663-670.
79. P.T. Lakkakorpi, P.P. Lehenkari, T.J. Rautiala and H.K. Väänänen (1996) Different calcium sensitivity in osteoclasts on glass and on bone and maintenance of cytoskeletal structures on bone in the presence of high extracellular calcium. J. Cell. Physiol. 168 668-677.
80. P.T. Lakkakorpi, G. Wesolowski, Z. Zimolo, G.A. Rodan and S.B. Rodan (1997) Phosphatidylinositol 3-kinase association with the osteoclast cytoskeleton, and its involvement in osteoclast attachment and spreading. Exp. Cell Res. 237 296-306.
81. P.F. Lange, L. Wartosch, T.J. Jentsch and J.C. Fuhrmann (2006) CIC-7 requires Ostm 1 as a beta-subunit to support bone resorption and lysosomal function. Nature 440 220-223.
82. E.R. Lee, L. Lamplugh, N.L. Shepard and J.S. Mort (1995) The septoclast, a cathepsin B-rich cell involved in the resorption of growth plate cartilage. J. Histochem. Cytochem. 43 525-536.
83. S.H. Lee, J. Rho, D. Jeong, J.Y. Sul, T. Kim, N. Kim, J.S. Kang, T. Miyamoto, T. Suda, S.K. Lee, R.J. Pignolo, B. Koczon-Jaremko, J. Lorenzo and Y. Choi (2006) v-ATPase V0 subunit d2-­deficient mice exhibit impaired osteoclast fusion and increased bone formation. Nat. Med. 12 1403-1409.
84. C.Y. Li, K.J. Jepsen, R.J. Majeska, J. Zhang, R. Ni, B.D. Gelb and M.B. Schaffler (2006) Mice lacking cathepsin K maintain bone remodeling but develop bone fragility despite high bone mass. J. Bone Miner. Res. 21 865-875.
85. Y.P. Li, W. Chen, Y. Liang, E. Li and P. Stashenko (2000) Atp6i-deficient mice exhibit severe osteoporosis due to loss of osteoclast-mediated extracellular acidification. Nat. Genet. 23 447-451.
86. S. Linder and M. Aepfelbacher (2003) Podosomes: Adhesion hot-spots of invasive cells. Trends Cell Biol. 13 376-385.
87. S. Linder and P. Kopp (2005) Podosomes at a glance. J. Cell Sci. 118 2079-2082.
88. F. Lorget, S. Kamel, R. Mentaverri, A. Wattel, M. Naassila, M. Maamer and M. Brazier (2000) High extracellular calcium concentrations directly stimulate osteoclast apoptosis. Biochem. Biophys. Res. Commun. 268 899-903.
89. S.P. Luckman, D.E. Hughes, F.P. Coxon, R. Graham, G. Russell and M.J. Rogers (1998) Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras. J. Bone Miner. Res. 13 581-589.
90. C. Luxenburg, D. Geblinder, E. Klein, K. Anderson, D. Hanein, B. Geiger and L. Addadi (2007) The architecture of the adhesive apparatus of cultured osteoclasts: From podosome formation to sealing zone assembly. PLoS ONE 2 e179.
91. P. Masarachia, M. Yamamoto, C.T. Leu, G. Rodan and L. Duong (1998) Histomorphometric evidence for echistatin inhibition of bone resorption in mice with secondary hyperparathyroidism. Endocrinology 139 1401-1410.
92. T. Matikainen, T. Hentunen and H.K. Väänänen (2000) The osteocytelike cell line MLO-Y4 inhibits osteoclastic bone resorption through transforming growth factor □: Enhancement by estrogen. Calcif. Tissue Int. 52 S94.
93. J.P. Mattsson, C. Skyman, H. Palokangas, K.H. Vaananen and D.J. Keeling (1997) Characterization and cellular distribution of the osteoclast ruffled membrane vacuolar H+-ATPase B-subunit using isoform-specific antibodies. J. Bone Miner. Res. 12 753-760.
94. G. Mbalaviele, H. Chen, B.F. Boyce, G.R. Mundy and T. Yoneda (1995) The role of cadherin in the generation of multinucleated osteoclasts from mononuclear precursors in murine marrow. J. Clin. Invest. 95 2757-2765.
95. K.P. McHugh, K. Hodivala-Dilke, M.H. Zheng, N. Namba, J. Lam, D. Novack, X. Feng, F.P. Ross, R.O. Hynes and S.L. Teitelbaum (2000) Mice lacking beta3 integrins are osteoclerotic because of dysfunctional osteoclasts. J. Clin. Invest. 105 433-440.
96. S. Mi, X. Lee, X. Li, G.M. Veldman, H. Finnerty, L. Racie, E. LaVallie, X.Y. Tang, P. Edouard, S. Howes, J.C. Keith Jr. and J.M. McCoy (2000) Syncytin is a captive retroviral envelope protein involved in human placental morphogenesis. Nature 403 785-789.
97. C. Minkin and J.M. Jennings (1972) Carbonic anhydrase and bone remodeling: Sulfonamide inhibition of bone resorption in organ culture. Science 176 1031-1033.
98. T. Miyazaki, A. Sanjay, L. Neff, S. Tanaka, W.C. Horne and R. Baron (2004) Src kinase activity is essential for osteoclast function. J. Biol. Chem. 279 17660-17666.
99. T. Miyazaki, S. Tanaka, A. Sanjay and R. Baron (2006) The role of c-Src kinase in the regulation of osteoclast function. Mod. Rheumatol. 16 68-74.
100. R. Morimoto, S. Uehara, S. Yatsushiro, N. Juge, Z. Hua, S. Senoh, N. Echigo, M. Hayashi, T. Mizoguchi, T. Ninomiya, N. Udagawa, H. Omote, A. Yamamoto, R.H. Edwards and Y. Moriyama (2006) Secretion of l-glutamate from osteoclasts through transcytosis. EMBO J. 25 4175-4186.
101. M. Moudjou, M. Lanotte and M. Bornens (1989) The fate of centrosome-microtubule network in monocyte derived giant cells. J. Cell Sci. 94 237-244.
102. M.T. Mulari, J.J. Salo and H.K. Väänänen (1998) Dynamics of microfilaments and microtubules during the resorption cycle in rat osteoclasts. J. Bone Miner. Res. 12 S341.
103. M. Mulari, H. Zhao, P. Lakkakorpi and H.K. Väänänen (2003) Ruffled border membrane in bone resorbing osteoclasts has distinct subdomains for secretion and degraded matrix uptake. Traffic 4 113-125.
104. M. Mulari, L. Patrikainen, T. Kaisto, K. Metsikkö, J. Salo and H.K. Väänänen (2003) The architecture of microtubular network and Golgi orientation in osteoclasts—major differences between avian and mammalian species. Exp. Cell Res. 285 221-235.
105. I. Nakamura, N. Takahasin, T. Sasaki, S. Tanaka, N. Vdaganea, H. Murakami, K. Kimura, Y. Kabyama, T. Kurokauea and T. Suda (1995) Wortmannin, a specific inhibitor of phosphatidylinositol-3 kinase, blocks osteoclastic bone resorption. FEBS Lett. 361 79-84.
106. I. Nakamura, L. Lipfert, G.A. Rodan and L.T. Duong (2001) Convergence of alpha(v)beta(3) integrin- and macrophage colony stimulating factor-mediated signals on phospholipase Cgamma in prefusion osteoclasts. J. Cell Biol. 152 361-373.
107. I. Nakamura, Y. Kadono, H. Takayanagi, E. Jimi, T. Miyazaki, H. Oda, K. Nakamura, S. Tanaka, G.A. Rodan and L.T. Duong (2002) IL-1 regulates cytoskeletal organization in osteoclasts via TNF rceptor-associated factor 6/c-Src complex. J. Immunol. 168 5103-5109.
108. L. Nakamura, E. Jimi, L.T. Duong, T. Sasaki, N. Takahashi, G.A. Rodan and T. Suda (1997) Tyrosine phosphory of p130Cas is involved in the actin filaments organization in osteoclasts. J. Biol. Chem. 273 11144-11149.
109. S. Nesbitt, A. Nesbit, M. Helfrich and M. Horton (1993) Biochemical characterization of human osteoclast integrins: Osteoclasts express alpha v beta 3, alpha 2 beta 1, and alpha v beta 1 integrins. J. Biol. Chem. 268 16737-16745.
110. S.A. Nesbitt and M.A. Horton (1997) Trafficking of matrix collagens through bone-resorbing osteoclasts. Science 276 266-269.
111. K. Niikura (2006) Vacuolar ATPase as a drug discovery target. Drug News Perspect. 19 139-144.
112. J.T. Palmer, C. Bryant, D.X. Wang, D.E. Davis, E.L. Setti, R.M. Rydzewski, S. Venkatraman, Z.Q. Tian, L.C. Burrill, R.V. Mendonca, E. Springman, J. McCarter, T. Chung, H. Cheung, J.W. Janc, M. McGrath, J.R. Somoza, P. Enriquez, Z.W. Yu, R.M. Strickley, L. Liu, M.C. Venuti, M.D. Percival, J.P. Falgueyret, P. Prasit, R. Oballa, D. Riendeau, R.N. Young, G. Wesolowski, S.B. Rodan, C. Johnson, D.B. Kimmel and G. Rodan (2005) Design and synthesis of tri-ring P3 benzamide-containing aminonitriles as potent, selective, orally effective inhibitors of cathepsin K. J. Med. Chem. 48 7520-7534.
113. H. Palokangas, M. Mulari and H.K. Vaananen (1997) Endocytic pathway from the basal plasma membrane to the ruffled border membrane in bone-resorbing osteoclasts. J. Cell Sci. 110 1767-1780.
114. T. Pap, G. Pap, K.M. Hummel, J.K. Franz, E. Jeisy, I. Sainsbury, R.E. Gay, M. Billingham, W. Neumann and S. Gay (1999) Membrane-type-1 matrix metalloproteinase is abundantly expressed in fibroblasts and osteoclasts at the bone–implant interface of aseptically loosened joint arthroplasties in situ. J. Rheumatol. 26 166-169.
115. Z.Q. Peng, T.A. Hentunen, G. Gros, P. Härkönen and H.K. Väänänen (2000) Bone changes in carbonic anhydrase II deficient mice. Calcif. Tissue Int. 52 S64.
116. U. Pettersson, O.M. Albagha, M. Mirolo, A. Taranta, A. Frattini, F.E. McGuigan, P. Vezzoni, A. Teti, W. van Hul, D.M. Reid, A. Villa and S.H. Ralston (2005) Polymorphisms of the CLCN7 gene are associated with BMD in women. J. Bone Miner. Res. 20 1960-1967.
117. M. Pfaff and P. Jurdic (2001) Podosomes in osteoclast-like cells: Structural analysis and cooperative roles of paxillin, proline-rich tyrosine kinase 2 (Pyk2) and integrin (alphaVbeta3). J. Cell Sci. 114 2775-2786.
118. K. Piper, A. Boyde and S.J. Jones (1992) The relationship between the number of nuclei of an osteoclast and its resorptive capability in vitro. Anat. Embryol. 186 229-291.
119. S.H. Ralston (1990) The pathogenesis of humoral hypercalcaemia of malignancy. J.N.M. Heersche, J.A. Kanis (Eds) Bone and Mineral Research/7 Amsterdam: Elsevier Science 139-173.
120. A. Ramirez, J. Faupel, I. Goebel, A. Stiller, S. Beyer, C. Stockle, C. Hasan, U. Bode, U. Kornak and C. Kubisch (2004) Identification of a novel mutation in the coding region of the grey-lethal gene OSTM1 in human malignant infantile osteoporosis. Hum. Mutat. 23 471-476.
121. H. Rao, G. Lu, H. Kajiya, V. Garcia-Palacios, N. Kurihara, J. Anderson, K. Patrene, D. Sheppard, H.C. Blair, J.J. Windle, S.J. Choi and G.D. Roodman (2006) Alpha9beta1: A novel osteoclast integrin that regulates osteoclast formation and function. J. Bone Miner. Res. 21 1657-1665.
122. S. Razzouk, M. Lieberherr and G. Cournot (1999) Rac-GTPase, osteoclast cytoskeleton and bone resorption. Eur. J. Cell Biol. 78 249-255.
123. D.P. Rice, H.J. Kim and I. Thesleff (1997) Detection of gelatinase B expression reveals osteoclastic bone resorption as a feature of early calvarial bone development. Bone 21 479-486.
124. R. Riihonen, C.T. Supuran, S. Parkkila, S. Pastorekova, H.K. Vaananen and T. Laitala-Leinonen (2007) Membrane-bound carbonic anhydrases in osteoclasts. Bone 40 1021-1031.
125. R.G. Russell (2006) Bisphosphonates: From bench to bedside. Ann. N. Y. Acad. Sci. 1068 367-401.
126. P. Saftig, E. Hunziker, O. Wehmeyer, S. Jones, A. Boyde, W. Rommerskirch, J.D. Moritz, P. Schu and K. von Figura (1998) Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice. Proc. Natl. Acad. Sci. USA 95 13453-13458.
127. S. Sakamoto and M. Sakamoto (1982) Biochemical and immunohistochemical studies on collagenase in resorbing bone in tissue culture: A novel hypothesis for the mechanism of bone resorption. J. Periodontal Res. 17 523-526.
128. Salo, J. (2002). Bone resorbing osteoclasts reveal two basal plasma membrane domains and transcytosis of degraded matrix material. Thesis. Acta Universitatis Ouluensis, D Medica, 697.
129. J. Salo, K. Metsikkö and H.K. Väänänen (1994) Novel transcytotic route for degraded bone matrix material in osteoclasts. Mol. Biol. Cell 5(Suppl), 431.
130. J. Salo, K. Metsikkö, H. Palokangas, P. Lehenkari and H.K. Väänänen (1996) Bone-resorbing osteoclasts reveal a dynamic division of basal membrane into two different domains. J. Cell Sci. 106 301-307.
131. J. Salo, P. Lehenkari, M. Mulari, K. Metsikkö and H.K. Vaananen (1997) Removal of osteoclast bone resorption products by transcytosis. Science 276 270-273.
132. F. Saltel, O. Destaing, F. Bard, D. Eichert and P. Jurdic (2004) Apatite-mediated actin dynamics in resorbing osteoclasts. Mol. Biol. Cell. 15 5231-5241.
133. A. Sanjay, A. Houghton, L. Neff, E. DiDomenico, C. Bardelay, E. Antoine, J. Levy, J. Gallit, D. Bowtell, W.C. Horne and R. Baron (2001) Cbl associates with Pyk2 and Src to regulate Src kinase activity, alpha(v)beta(3) integrin-mediated signaling, cell adhesion, and osteoclast motility. J. Cell Biol. 152 181-195.
134. M. Sato, M.K. Sardana, W.A. Grasser, V.M. Garskky, J.M. Murray and R.J. Gould (1990) Echistatin is a potent inhibitor of bone resorption in culture. J. Cell Biol. 111 1713-1723.
135. T. Sato, M. del Carmen Ovejero, P. Hou, A.M. Heegaard, M. Kumegawa, N.T. Foged and J.M. Delaisse (1997) Identification of the membrane-type matrix metalloproteinase MT1-MMP in osteoclasts. J. Cell Sci. 110 589-596.
136. S. Schaller, K. Henriksen, M.G. Sorensen and M.A. Karsdal (2005) The role of chloride channels in osteoclasts: CIC-7 as a target for osteoporosis treatment. Drug News Perspect. 18 489-495.
137. P.L. Schwartzberg, L. Xing, O. Hoffmann, C.A. Lowell, L. Garrett, B.F. Boyce and H.E. Varmus (1997) Rescue of osteoclast function by transgenic expression of kinase-dificient Src in src–/– mutant mice. Genes Dev. 11 2835-2844.
138. J.C. Scimeca, A. Franchi, C. Trojani, H. Parrinello, J. Grosgeorge, C. Robert, O. Jaillon, C. Poirier, P. Gaudray and G.F. Carle (2000) The gene encoding the mouse homologue of the human osteoclast-specific 116-kDa V-ATPase subunit bears a deletion in osteosclerotic (oc/oc) mutants. Bone 26 207-213.
139. K.S. Selander, P.L. Harkonen, E. Valve, J. Monkkonen, R. Hannuniemi and H.K. Väänänen (1996) Calcitonin promotes osteoclast survival in vitro. Mol. Cell. Endocrinol. 122 119-129.
140. K.S. Selander, J. Monkkonen, E.K. Karhukorpi, P. Harkonen, . Hannuniemi and H.K. Väänänen (1996) Characteristics of clodronate-induced apoptosis in osteoclasts and macrophages. Mol. Pharmacol. 50 1127-1138.
141. W.S. Sly and P.Y. Hu (1995) Human carbonic anhydrases and carbonic anhydrase deficiences. Annu. Rev. Biochem. 64 375-401.
142. F. Solari, C. Domenget, V. Gire, C. Woods, E. Lazarides, B. Rousset and P. Jurdic (1995) Multinucleated cells can continuously generate mononucleated cells in the absence of mitosis: A study of cells of the avian osteoclast lineage. J. Cell Sci. 108 3233-3241.
143. P. Soriano, C. Montgomery, R. Geske and A. Bradley (1991) Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 64 693-702.
144. P. Spessotto, F.M. Rossi, M. Degan, R. Di Francia, R. Perris, A. Colombatti and V. Gattei (2002) Hyaluronan-CD44 interaction hampers migration of osteoclast-like cells by down-regulating MMP-9. J. Cell Biol. 158 1133-1144.
145. G. Stenbeck and M.A. Horton (2000) A new specialized cell–matrix interaction in actively resorbing osteoclasts. J. Cell Sci. 113 1577-1587.
146. T. Sugiyama and S. Kusuhara (1994) The kinetics of actin filaments in osteoclasts on chicken medullary bone during the egg-laying cycle. Bone 15 351-353.
147. Y. Sun, K.G. Buki, O. Ettala, J. Vääräniemi and H.K. Väänänen (2005) Possible role of direct Rac1–Rab7 interaction in ruffled border formation of osteoclasts. J. Biol. Chem. 280 32356-32361.
148. K. Sundquist, P. Lakkakorpi, B. Wallmark and K. Väänänen (1990) Inhibition of osteoclast proton transport by bafilomycin A1 abolishes bone resorption. Biochem. Biophys. Res. Commun. 168 309-313.
149. K.T. Sundquist and S.C. Marks Jr (1994) Bafilomycin A1 inhibits bone resorption and tooth eruption in vivo. J. Bone Miner. Res. 9 1575-1582.
150. H. Suzuki, I. Nakamura, N. Takahashi, T. Ikuhara, H. Matsuzaki, M. Hori and T. Suda (1996) Calcitonin-induced changes in the cytoskeleton are mediated by a signal pathway associated with protein kinase A in osteoclasts. Endocrinology 137 4685-4690.
151. S. Takeshita, N. Namba, J.J. Zhao, Y. Jiang, H.K. Genant, M.J. Silva, M.D. Brodt, C.D. Helgason, J. Kalesnikoff, M.J. Rauh, R.K. Humphries, G. Krystal, S.L. Teitelbaum and F.P. Ross (2002) SHIP-deficient mice are severely osteoporotic due to increased number of hyper-resorptive osteoclasts. Nat. Med. 8 943-949.
152. S. Tanaka, N. Takahashi, N. Udagauea, H. Murakami, I. Nakamura, T. Kurokauea and T. Suda (1995) Possible involvement of focal adhesion kinase, p125 (FAK), in osteoclastic bone resorption. J. Cell. Biochem. 58 424-435.
153. S. Tanaka, T. Miyazaki, A. Fukuda, T. Akiyama, Y. Kadono, H. Wakeyama, S. Kono, S. Hoshikawa, M. Nakamura, Y. Ohshima, A. Hikita, I. Nakamura and K. Nakamura (2006) Ann. N. Y. Acad. Sci. 1068 180-186.
154. S. Tehrani, R. Faccio, I. Chandrasekar, F.P. Ross and J.A. Cooper (2006) Cortactin has an essential and specific role in osteoclast actin assembly. Mol. Biol. Cell. 17 2882-2895.
155. D.P. Trebec, D. Chandra, A. Gramoun, K. Li, J.N. Heersche and M.F. Manoison (2007) Increased expression of activating factors in large osteoclasts could explain their excessive activity in osteolytic diseases. J. Cell Biochem (Epub ahead of print).
156. B.R. Troen (2006) The regulation of cathepsin K gene expression. Ann. N. Y. Acad. Sci. 1068 165-172.
157. J. Tuukkanen and H.K. Väänänen (1986) Omeprazole, a specific inhibitor of H+-K+ATPase, inhibits bone resorption in vitro. Calcif. Tissue Int. 38 123-125.
158. H.K. Väänänen and M. Horton (1995) The osteoclast clear zone is a specialized cell-extracellular matrix adhesion structure. J. Cell Sci. 108 2729-2732.
159. H.K. Väänänen, E.K. Karhukorpi, K. Sundquist, B. Wallmark, I. Roininen, T. Hentunen, J. Tuukkanen and P. Lakkakorpi (1990) Evidence for the presence of a proton pump of the vacuolar H+-ATPase type in the ruffled borders of osteoclasts. J. Cell Biol. 111 1305-1311.
160. H.K. Väänänen, H. Zhao, M. Mulari and J.M. Halleen (2000) The cell biology of osteoclast function. J. Cell Sci. 113 377-381.
161. J. Vääräniemi, J. Halleen, K. Kaarlonen, H. Ylipahkala, S. Alatalo, G. Andersson, H. Kaija, P. Vihko and H.K. Väänänen (2004) Intracellular machinery for matrix degradation in bone resorbing osteoclasts. J. Bone Miner. Res. 19 1432-1440.
162. U. Valcourt, B. Merle, E. Gineyts, S. Giquet-Carrin, P.D. Delmas and P. Garnerno (2007) Non-enzymatic glycation of bone collagen modifies osteoclastic activity and differentiation. J. Biol. Chem. 282 5691-5703.
163. B.J. Votta, M.A. Levy, A. Badger, J. Bradbeer, R.A. Dodds, I.E. James, S. Thompson, M.J. Bossard, T. Carr, J.R. Connor, T.A. Tomaszek, L. Szewczuk, F.H. Drake, D.F. Veber and M. Gowen (1997) Peptide aldehyde inhibitors of cathepsin K inhibit bone resorption both in vitro and in vivo. J. Bone Miner. Res. 12 1396-1406.
164. T.H. Vu, J.M. Shipley, G. Bergers, J.E. Berger, J.A. Helms, D. Hanahan, S.D. Shapiro, R.M. Senior and Z. Werb (1998) MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93 411-422.
165. Q. Wang, Y. Xie, Q.S. Du, X.J. Wu, X. Feng, L. Mei, J.M. McDonald and W.C. Xiong (2003) Regulation of the formation of osteoclastic actin rings by praline-rich tyrosine kinase 2 interacting with gelsolin. J. Cell Biol. 160 565-575.
166. J.T. Woo, M. Kawatani, M. Kato, T. Shinki, T. Yonezawa, N. Kanoh, H. Nakagawa, M. Takami, H.K. Lee, P.H. Stern, K. Nagai and H. Osada (2006) Reveromycin A, an agent for osteoporosis, inhibits bone resorption by inducing apoptosis specifically in osteoclasts. Proc. Natl. Acad. Sci. USA 103 4729-4734.
167. L. Xia, J. Kilb, H. Wex, Z. Li, A. Lipyansky, V. Breuil, L. Stein, J.T. Palmer, D.W. Dempster and D. Bromme (1999) Localization of rat cathepsin K in osteoclasts and resorption pits: Inhibition of bone resorption and cathepsin K-activity by peptidyl vinyl sulfones. Biol. Chem. 380 679-687.
168. M. Yagi, T. Miyamoto, Y. Sawatani, K. Iwamoto, N. Hosogane, N. Fujita, K. Morita, K. Ninomiya, T. Suzuki, K. Miyamoto, Y. Oike, M. Takeya, Y. Toyama and T. Suda (2005) DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells. J. Exp. Med. 202 345-351.
169. M. Yamaki, H. Nakamura, N. Takahashi, N. Udagawa and H. Ozawa (2005) Transcytosis of calcium from bone by osteoclast-like cells evidenced by direct visualization of calcium in cells. Arch. Biochem. Biophys. 440 10-17.
170. M. Yamamoto, J.E. Fisher, M. Gentile, J.G. Seedor, C.T. Leu, S. Rodan and G.A. Rodan (1998) Endocrinology 139 1411-1419.
171. A. Zambonin-Zallone, A. Teti, A. Carano and P.C. Marchisio (1988) The distribution of podosomes in osteoclasts cultured on bone laminae: Effect of retinol. J. Bone Miner. Res. 3 517-523.
172. D. Zhang, N. Udagawa, I. Nakamura, H. Murakami, S. Saito, K. Yamasaki, Y. Shibasaki, N. Morii, S. Narumiya, N. Takahashi and T. Suda (1995) The small GTP-binding protein, rho p21, is involved in bone resorption by regulating cytoskeletal organization in osteoclasts. J. Cell Sci. 108 2285-2292.
173. H. Zhao, M. Mulari, V. Parikka, T. Hentunen, P. Lakkakorpi and H.K. Väänänen (2000) Osteoclast ruffled border membrane contains different subdomains for exocytosis and endocytosis. Calcif. Tissue Int. 52 S63.
174. H. Zhao, V. Parikka, T. Laitala-Leinonen and H.K. Väänänen (2001) Downregulation of small GTPase Rab7 impairs osteoclast polarization and bone resorption. J. Biol. Chem. 276 39295-39302.
175. Z. Zhou, I. Immel, C.X. Xi, A. Bierhaus, X. Feng, L. Mei, P. Nawroth, D.M. Stern and W.C. Xiong (2006) Regulation of osteoclast function and bone mass by RAGE. J. Exp. Med. 203 1067-1080.
176. W. Zou, H. Kitaura, J. Reeve, F. Long, V.L. Tybulewicz, S.J. Shattil, M.H. Ginsberg, F.P. Ross and S.L. Teitelbaum (2007) Syk, c-Src, the alpha v beta3 integrin, and ITAM immunoreceptors, in concert, regulate osteoclastic bone resorption. J. Cell Biol. 176 877-888.
177. J. Zuo, J. Jiang, S.H. Chen, S. Vergara, Y. Gong, J. Xue, H. Huang, M. Kaku and L.S. Holliday (2006) Actin binding activity of subunit B of vacuolar H+-ATPase is involved in its targeting to ruffled membranes of osteoclasts. J. Bone Miner. Res. 21 714-721.